Pharmaceutical Manufacturer Assertio Therapeutics, Inc.

IL 2025 Independent Pharmacies

DOJ False Claims Act

Penalty

$3.6 million

Outcome

Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product

Details

Pharmaceutical Manufacturer Assertio Therapeutics, Inc. — DOJ Enforcement (2025)

Outcome: Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works